We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.
TODAY'S HIGH
87.8
TODAY'S LOW
84.85
52 WEEK HIGH
198.8
52 WEEK LOW
81.1
% of Shares Held by
All Insider
71.86%
% of Shares Held by
Institutions
0.00%
% of Float Held by
Institutions
0.00%
Number of Institutions
Holding Shares
0
MARKET CAP
742.82 Cr.
ETERPRISE VALUE
955.43 Cr.
NO. OF SHARES
8.46 Cr.
BOOK VALUE
53.687
DIV. YIELD
0.3%
DEBT
246.93 Cr.
GROSS PROFIT
185.44 Cr.
CASH
30.08 Cr.
REVENUE
634.83 Cr.
REVENUE/SHARE
75.006
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Investments | 0 | 0 | 0 | -8.02 Cr. |
| Change To Liabilities | 20.94 Cr. | -3.75 Cr. | 8.98 Cr. | -28.04 Cr. |
| Total cashflows from Investing Activities | -151.59 Cr. | -42.56 Cr. | -34.67 Cr. | -16.57 Cr. |
| Net Borrowings | 98.16 Cr. | 8.45 Cr. | -2.46 Cr. | -3.02 Cr. |
| Total Cash from Financing Activities | 92.01 Cr. | -2.40 Cr. | -12.91 Cr. | -14.89 Cr. |
| Other Liabilities | 32.13 Cr. | -8.76 Cr. | -3.57 Cr. | -2.31 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 62.52 Cr. | 31.57 Cr. | 40.04 Cr. | 31.74 Cr. |
| Change in Cash | 30.87 Cr. | -5.25 Cr. | 2.16 Cr. | 34.55 Lakhs |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 90.45 Cr. | 39.71 Cr. | 49.75 Cr. | 31.81 Cr. |
| Depreciation | 22.18 Cr. | 21.95 Cr. | 19.16 Cr. | 19.76 Cr. |
| Other Cashflows from Investing Activities | 2.36 Lakhs | 3.67 Lakhs | 7.19 Lakhs | 11 k |
| Dividends Paid | 0 | -4.23 Cr. | -2.11 Cr. | -2.03 Cr. |
| Change to Inventory | -8.58 Cr. | 7.19 Cr. | -28.92 Cr. | -14.95 Cr. |
| Change to Account Receivables | -56.98 Cr. | -22.74 Cr. | -1.97 Cr. | -2.86 Cr. |
| Other Cashflows from Financing Activities | -6.14 Cr. | -6.62 Cr. | -8.33 Cr. | -9.83 Cr. |
| Change to Net Income | 17.96 Cr. | 13.60 Cr. | 16.35 Cr. | 28.62 Cr. |
| Capital Expenditures | -151.74 Cr. | -42.73 Cr. | -34.83 Cr. | -8.55 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 92.68 Cr. | 49.64 Cr. | 60.94 Cr. | 51.64 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 101.43 Cr. | 60.97 Cr. | 72.95 Cr. | 74.76 Cr. |
| Selling General Administrative | 41.49 Cr. | 41.01 Cr. | 37.24 Cr. | 34.25 Cr. |
| Gross Profit | 185.44 Cr. | 133.85 Cr. | 138.89 Cr. | 139.22 Cr. |
| Ebit | 101.43 Cr. | 60.97 Cr. | 72.95 Cr. | 74.76 Cr. |
| Operating Income | 101.43 Cr. | 60.97 Cr. | 72.95 Cr. | 74.76 Cr. |
| Other Operating Expenses | 20.23 Cr. | 9.80 Cr. | 9.41 Cr. | 10.30 Cr. |
| Interest Expense | -10.25 Cr. | -11.19 Cr. | -11.41 Cr. | -14.77 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 30.15 Cr. | 18.06 Cr. | 20.90 Cr. | 19.89 Cr. |
| Total Revenue | 565.14 Cr. | 414.30 Cr. | 466.74 Cr. | 463.91 Cr. |
| Total Operating Expenses | 463.71 Cr. | 353.32 Cr. | 393.79 Cr. | 389.14 Cr. |
| Cost of Revenue | 379.70 Cr. | 280.44 Cr. | 327.85 Cr. | 324.68 Cr. |
| Total Other Income Expense Net | -8.74 Cr. | -11.33 Cr. | -12 Cr. | -23.11 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 62.52 Cr. | 31.57 Cr. | 40.04 Cr. | 31.74 Cr. |
| Net Income Applicable to Common Shares | 62.52 Cr. | 31.57 Cr. | 40.04 Cr. | 31.74 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Intangible Assets | 1.60 Cr. | 83.26 Lakhs | 1.14 Cr. | 36.27 Lakhs |
| Capital Surplus | 69.81 Cr. | 69.81 Cr. | 69.81 Cr. | 69.81 Cr. |
| Total Liabilities | 401.68 Cr. | 259.67 Cr. | 236.89 Cr. | 218.03 Cr. |
| Stock Holder Equity | 410.52 Cr. | 348.23 Cr. | 321.91 Cr. | 284.48 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 21.61 Cr. | 14.13 Cr. | 10.81 Cr. | 5.32 Cr. |
| Total Assets | 812.21 Cr. | 607.91 Cr. | 558.81 Cr. | 502.52 Cr. |
| Common Stock | 8.46 Cr. | 8.46 Cr. | 8.46 Cr. | 8.46 Cr. |
| Retained Earnings | 330.69 Cr. | 268.40 Cr. | 242.08 Cr. | 204.65 Cr. |
| Other Liabilities | 55.69 Cr. | 41.47 Cr. | 32.13 Cr. | 25.18 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 1.55 Cr. | 1.55 Cr. | 1.55 Cr. | 1.55 Cr. |
| Other Assets | 11.47 Cr. | 40.71 Cr. | 24.67 Cr. | 18.19 Cr. |
| Cash | 40.42 Cr. | 9.54 Cr. | 14.79 Cr. | 12.63 Cr. |
| Current Liabilities | 194.09 Cr. | 145.20 Cr. | 142.54 Cr. | 121.45 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 31.82 Cr. | 22.91 Cr. | 10.75 Cr. | 16.33 Cr. |
| Other Stockholder Equity | 1.55 Cr. | 1.55 Cr. | 1.55 Cr. | 1.55 Cr. |
| Property Plant Equipment | 462.50 Cr. | 321.77 Cr. | 298.40 Cr. | 287.09 Cr. |
| Total Cur. Assets | 309.32 Cr. | 218.78 Cr. | 207.59 Cr. | 168.48 Cr. |
| Long Term Investments | 27.30 Cr. | 25.81 Cr. | 26.99 Cr. | 28.38 Cr. |
| Net Tangible Assets | 408.92 Cr. | 347.40 Cr. | 320.76 Cr. | 284.12 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 122.64 Cr. | 67.85 Cr. | 51.70 Cr. | 45.59 Cr. |
| Long Term Debt | 147.83 Cr. | 68.22 Cr. | 62.21 Cr. | 71.39 Cr. |
| Inventory | 137.78 Cr. | 129.20 Cr. | 136.39 Cr. | 107.47 Cr. |
| Accounts Payable | 54.95 Cr. | 39.55 Cr. | 42.17 Cr. | 32.69 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account